BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bech EM, Pedersen SL, Jensen KJ. Chemical Strategies for Half-Life Extension of Biopharmaceuticals: Lipidation and Its Alternatives. ACS Med Chem Lett 2018;9:577-80. [PMID: 30034579 DOI: 10.1021/acsmedchemlett.8b00226] [Cited by in Crossref: 67] [Cited by in F6Publishing: 68] [Article Influence: 13.4] [Reference Citation Analysis]
Number Citing Articles
1 Dopierała K, Weiss M, Krajewska M, Błońska J. Towards understanding the binding affinity of lipid drug carriers to serum albumin. Chem Phys Lipids 2023;250:105271. [PMID: 36509110 DOI: 10.1016/j.chemphyslip.2022.105271] [Reference Citation Analysis]
2 Esposito S, Krick A, Pasquier O, Bonche F, Ingenito R, Magotti P, Bianchi E, Monteagudo E, Gallo M, Cicero DO, Orsatti L, Veneziano M, Caretti F, Mele R, Roversi D, Gennari N, Brasseur D, Gauzy-lazo L, Duclos O, Mauriac C, Illiano S, Mallart S. Fatty acid acylated peptide therapeutics: discovery of omega-n oxidation of the lipid chain as a novel metabolic pathway in preclinical species. Journal of Pharmaceutical and Biomedical Analysis 2023. [DOI: 10.1016/j.jpba.2023.115256] [Reference Citation Analysis]
3 Nguyen TD, Bordeau BM, Zhang Y, Mattle AG, Balthasar JP. Half-Life Extension and Biodistribution Modulation of Biotherapeutics via Red Blood Cell Hitch-Hiking with Novel Anti-Band 3 Single-Domain Antibodies. Int J Mol Sci 2022;24. [PMID: 36613917 DOI: 10.3390/ijms24010475] [Reference Citation Analysis]
4 Chen H, Chen X, Chen X, Lin S, Cheng J, You L, Xiong C, Cai X, Wang S. New perspectives on fabrication of peptide-based nanomaterials in food industry: A review. Trends in Food Science & Technology 2022;129:49-60. [DOI: 10.1016/j.tifs.2022.09.004] [Reference Citation Analysis]
5 Fagihi MHA, Bhattacharjee S. Amyloid Fibrillation of Insulin: Amelioration Strategies and Implications for Translation. ACS Pharmacol Transl Sci . [DOI: 10.1021/acsptsci.2c00174] [Reference Citation Analysis]
6 Wong J, Kirberger S, Qiu R, Ekanayake A, Kelich P, Sarkar S, Alvizo-paez E, Miao J, Kalhor-monfared S, Dwyer J, Nuss J, Lin Y, Macauley M, Vukovic L, Pomerantz W, Derda R. Genetically-Encoded Discovery of Perfluoroaryl-Macrocycles that Bind to Albumin and Exhibit Extended Circulation in-vivo.. [DOI: 10.21203/rs.3.rs-1999287/v1] [Reference Citation Analysis]
7 Esposito S Dr, Orsatti L Dr, Pucci V Dr. Subcutaneous Catabolism of Peptide Therapeutics: Bioanalytical Approaches and ADME Considerations. Xenobiotica 2022;:1-35. [PMID: 36039395 DOI: 10.1080/00498254.2022.2119180] [Reference Citation Analysis]
8 Xu L, Guan R, Yu B, Li Y, Liu H, Jiang Y. Fluorene methoxycarbonyl-PEG-deferoxamine conjugates "hitchhike" with albumin in situ for iron overload therapy. Int J Pharm 2022;625:122136. [PMID: 36029994 DOI: 10.1016/j.ijpharm.2022.122136] [Reference Citation Analysis]
9 Wong JY, Kirberger SE, Qiu R, Ekanayake AI, Kelich P, Sarkar S, Alvizo-paez ER, Miao J, Kalhor-monfared S, Dwyer JJ, Nuss JM, Lin Y, Macauley MS, Vukovic L, Pomerantz WC, Derda R. Genetically-Encoded Discovery of Perfluoroaryl-Macrocycles that Bind to Albumin and Exhibit Extended Circulation in-vivo.. [DOI: 10.1101/2022.08.22.504611] [Reference Citation Analysis]
10 Ibnat N, Zaman R, Uddin MB, Chowdhury E, Lee CY. Improved systemic half-life of glucagon-like peptide-1-loaded carbonate apatite nanoparticles in rats. World J Diabetes 2022; 13(8): 613-621 [DOI: 10.4239/wjd.v13.i8.613] [Reference Citation Analysis]
11 Ostróżka-Cieślik A. The Potential of Pharmaceutical Hydrogels in the Formulation of Topical Administration Hormone Drugs. Polymers (Basel) 2022;14:3307. [PMID: 36015564 DOI: 10.3390/polym14163307] [Reference Citation Analysis]
12 Huang C, Palani A, Yang Z, Deng Q, Reddy V, Nargund RP, Lin S, Altezza S, Bianchi E, Orvieto F, Carrington P. Discovery of Insulin/GLP-1/Glucagon Triagonists for the Treatment of Diabetes and Obesity. ACS Med Chem Lett . [DOI: 10.1021/acsmedchemlett.2c00218] [Reference Citation Analysis]
13 Upadhyaya P, Kristensson J, Lahdenranta J, Repash E, Ma J, Kublin J, Mudd GE, Luus L, Jeffrey P, Hurov K, McDonnell K, Keen N. Discovery and Optimization of a Synthetic Class of Nectin-4-Targeted CD137 Agonists for Immuno-oncology. J Med Chem 2022. [PMID: 35819182 DOI: 10.1021/acs.jmedchem.2c00505] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Linciano S, Moro G, Zorzi A, Angelini A. Molecular analysis and therapeutic applications of human serum albumin-fatty acid interactions. J Control Release 2022;348:115-26. [PMID: 35643382 DOI: 10.1016/j.jconrel.2022.05.038] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Park J, Ngo HV, Jin H, Lee KW, Lee B. Hydroxyl Group-Targeted Conjugate and Its Self-Assembled Nanoparticle of Peptide Drug: Effect of Degree of Saturation of Fatty Acids and Modification of Physicochemical Properties. IJN 2022;Volume 17:2243-60. [DOI: 10.2147/ijn.s356804] [Reference Citation Analysis]
16 Molitoris BA, Sandoval RM, Yadav SPS, Wagner MC. Albumin Uptake and Processing by the Proximal Tubule: Physiologic, Pathologic and Therapeutic Implications. Physiological Reviews. [DOI: 10.1152/physrev.00014.2021] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
17 Li Q, Ma S, Zhang X, Zhai Z, Zhou L, Tao H, Wang Y, Pan J. DDPD 1.0: a manually curated and standardized database of digital properties of approved drugs for drug-likeness evaluation and drug development. Database 2022;2022. [DOI: 10.1093/database/baab083] [Reference Citation Analysis]
18 Rao SS, Somayaji Y, Kulal A. Synthesis and Evaluation of the Insulin-Albumin Conjugate with Prolonged Glycemic Control. ACS Omega 2022;7:5131-8. [PMID: 35187328 DOI: 10.1021/acsomega.1c06119] [Reference Citation Analysis]
19 Alexopoulou F, Bech EM, Pedersen SL, Thorbek DD, Leurs U, Rudkjær LCB, Fosgerau K, Hansen HH, Vrang N, Jelsing J, Elster L. Lipidated PrRP31 metabolites are long acting dual GPR10 and NPFF2 receptor agonists with potent body weight lowering effect. Sci Rep 2022;12:1696. [PMID: 35105898 DOI: 10.1038/s41598-022-05310-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Engudar G, Rodríguez-Rodríguez C, Mishra NK, Bergamo M, Amouroux G, Jensen KJ, Saatchi K, Häfeli UO. Metal-ion coordinated self-assembly of human insulin directs kinetics of insulin release as determined by preclinical SPECT/CT imaging. J Control Release 2022:S0168-3659(22)00046-3. [PMID: 35085699 DOI: 10.1016/j.jconrel.2022.01.032] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Xu YD, Tian L, Lai RY, Li Z, Procházková E, Ho J, Stenzel MH. Development of an Albumin–Polymer Bioconjugate via Covalent Conjugation and Supramolecular Interactions. Bioconjugate Chem . [DOI: 10.1021/acs.bioconjchem.1c00536] [Reference Citation Analysis]
22 Nikravesh FY, Shirkhani S, Bayat E, Talebkhan Y, Mirabzadeh E, Sabzalinejad M, Aliabadi HAM, Nematollahi L, Ardakani YH, Sardari S. Extension of human GCSF serum half-life by the fusion of albumin binding domain. Sci Rep 2022;12:667. [PMID: 35027593 DOI: 10.1038/s41598-021-04560-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
23 Gallo M, Vanni D, Esposito S, Alaimo N, Orvieto F, Rulli F, Missineo A, Caretti F, Bonelli F, Veneziano M, Orsatti L, Monteagudo E. Oligomerization, albumin binding and catabolism of therapeutic peptides in the subcutaneous compartment: An investigation on lipidated GLP-1 analogs. J Pharm Biomed Anal 2022;210:114566. [PMID: 35042144 DOI: 10.1016/j.jpba.2021.114566] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
24 Gabe MBN, Skov-Jeppesen K, Gasbjerg LS, Schiellerup SP, Martinussen C, Gadgaard S, Boer GA, Oeke J, Torz LJ, Veedfald S, Svane MS, Bojsen-Møller KN, Madsbad S, Holst JJ, Hartmann B, Rosenkilde MM. GIP and GLP-2 together improve bone turnover in humans supporting GIPR-GLP-2R co-agonists as future osteoporosis treatment. Pharmacol Res 2022;176:106058. [PMID: 34995796 DOI: 10.1016/j.phrs.2022.106058] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
25 Revell JD. Design and synthesis of chemically modified peptides and proteins —critical considerations for oral delivery. Oral Delivery of Therapeutic Peptides and Proteins 2022. [DOI: 10.1016/b978-0-12-821061-1.00003-4] [Reference Citation Analysis]
26 Mayendraraj A, Rosenkilde MM, Gasbjerg LS. GLP-1 and GIP receptor signaling in beta cells – A review of receptor interactions and co-stimulation. Peptides 2022. [DOI: 10.1016/j.peptides.2022.170749] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
27 Ganesh AN, Garad S, Sanchez-felix MV. A biopharmaceutics perspective on oral peptide developability and drug delivery. Oral Delivery of Therapeutic Peptides and Proteins 2022. [DOI: 10.1016/b978-0-12-821061-1.00009-5] [Reference Citation Analysis]
28 Kartha S, Ghimire P, Winkelstein BA. Inhibiting spinal secretory phospholipase A2 after painful nerve root injury attenuates established pain and spinal neuronal hyperexcitability by altering spinal glutamatergic signaling. Mol Pain 2021;17:17448069211066221. [PMID: 34919471 DOI: 10.1177/17448069211066221] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
29 Bossart M, Wagner M, Elvert R, Evers A, Hübschle T, Kloeckener T, Lorenz K, Moessinger C, Eriksson O, Velikyan I, Pierrou S, Johansson L, Dietert G, Dietz-Baum Y, Kissner T, Nowotny I, Einig C, Jan C, Rharbaoui F, Gassenhuber J, Prochnow HP, Agueusop I, Porksen N, Smith WB, Nitsche A, Konkar A. Effects on weight loss and glycemic control with SAR441255, a potent unimolecular peptide GLP-1/GIP/GCG receptor triagonist. Cell Metab 2021:S1550-4131(21)00624-0. [PMID: 34932984 DOI: 10.1016/j.cmet.2021.12.005] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 14.5] [Reference Citation Analysis]
30 La Manna S, Di Natale C, Onesto V, Marasco D. Self-Assembling Peptides: From Design to Biomedical Applications. Int J Mol Sci 2021;22:12662. [PMID: 34884467 DOI: 10.3390/ijms222312662] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
31 Pechenov S, Revell J, Will S, Naylor J, Tyagi P, Patel C, Liang L, Tseng L, Huang Y, Rosenbaum AI, Balic K, Konkar A, Grimsby J, Subramony JA. Development of an orally delivered GLP-1 receptor agonist through peptide engineering and drug delivery to treat chronic disease. Sci Rep 2021;11:22521. [PMID: 34795324 DOI: 10.1038/s41598-021-01750-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
32 Koch NG, Goettig P, Rappsilber J, Budisa N. Engineering Pyrrolysyl-tRNA Synthetase for the Incorporation of Non-Canonical Amino Acids with Smaller Side Chains. Int J Mol Sci 2021;22:11194. [PMID: 34681855 DOI: 10.3390/ijms222011194] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
33 Tan H, Su W, Zhang W, Zhang J, Sattler M, Zou P. Generation of novel long-acting GLP-1R agonists using DARPins as a scaffold. Int J Pharm 2021;607:121043. [PMID: 34450223 DOI: 10.1016/j.ijpharm.2021.121043] [Reference Citation Analysis]
34 Ruan S, Yang G, Dong Y, Shangguan W, Lu W. Discovery of a Long-Acting Parathyroid Hormone 1-34 Analogue to Treat Hypoparathyroidism. Mol Pharm 2021;18:3260-71. [PMID: 34482698 DOI: 10.1021/acs.molpharmaceut.1c00149] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
35 Han S, Mei L, Quach T, Porter C, Trevaskis N. Lipophilic Conjugates of Drugs: A Tool to Improve Drug Pharmacokinetic and Therapeutic Profiles. Pharm Res 2021;38:1497-518. [PMID: 34463935 DOI: 10.1007/s11095-021-03093-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
36 Yim V, Hermant YO, Harris PWR, Brimble MA. Synthesis of Lipopeptides by CLipPA Chemistry. Methods Mol Biol 2021;2355:253-63. [PMID: 34386963 DOI: 10.1007/978-1-0716-1617-8_19] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
37 Kruse T, Hansen JL, Dahl K, Schäffer L, Sensfuss U, Poulsen C, Schlein M, Hansen AMK, Jeppesen CB, Dornonville de la Cour C, Clausen TR, Johansson E, Fulle S, Skyggebjerg RB, Raun K. Development of Cagrilintide, a Long-Acting Amylin Analogue. J Med Chem 2021;64:11183-94. [PMID: 34288673 DOI: 10.1021/acs.jmedchem.1c00565] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
38 Ruan S, Dong Y, Lu J, Zhao M, Lu W, Feng J. Synthesis of a Novel PTH1–34 Analog with Increased Human Serum Albumin Affinity. Pharmaceutical Fronts 2021;03:e23-9. [DOI: 10.1055/s-0041-1731299] [Reference Citation Analysis]
39 Rondon A, Mahri S, Morales‐yanez F, Dumoulin M, Vanbever R. Protein Engineering Strategies for Improved Pharmacokinetics. Adv Funct Mater 2021;31:2101633. [DOI: 10.1002/adfm.202101633] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
40 Zhang C, Wu L, Liu X, Gao J, Liu S, Wu J, Huang D, Wang Z, Su X. Discovery of Novel PTP1B Inhibitors Derived from the BH3 Domain of Proapoptotic Bcl-2 Proteins with Antidiabetic Potency. ACS Med Chem Lett 2021;12:1017-23. [PMID: 34141087 DOI: 10.1021/acsmedchemlett.1c00174] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
41 Smallwood TB, Clark RJ. Advances in venom peptide drug discovery: where are we at and where are we heading? Expert Opin Drug Discov 2021;:1-11. [PMID: 33914674 DOI: 10.1080/17460441.2021.1922386] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
42 Zhang Q, Ruan S, Wu Y, Zhang J, Lu J, Feng J. Extending the in vivo Half-Life of Adalimumab Fab via Sortase A-Mediated Conjugation of Adalimumab Fab with Modified Fatty Acids. Pharmaceutical Fronts 2021;02:e160-7. [DOI: 10.1055/s-0041-1728817] [Reference Citation Analysis]
43 Rani A, De Leon-Rodriguez LM, Kavianinia I, McGillivray DJ, Williams DE, Brimble MA. Synthesis and characterization of mono S-lipidated peptide hydrogels: a platform for the preparation of reactive oxygen species responsive materials. Org Biomol Chem 2021;19:3665-77. [PMID: 33908574 DOI: 10.1039/d1ob00355k] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
44 Ekanayake AI, Sobze L, Kelich P, Youk J, Bennett NJ, Mukherjee R, Bhardwaj A, Wuest F, Vukovic L, Derda R. Genetically Encoded Fragment-Based Discovery from Phage-Displayed Macrocyclic Libraries with Genetically Encoded Unnatural Pharmacophores. J Am Chem Soc 2021;143:5497-507. [PMID: 33784084 DOI: 10.1021/jacs.1c01186] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 7.5] [Reference Citation Analysis]
45 Takahara M, Mochizuki S, Wakabayashi R, Minamihata K, Goto M, Sakurai K, Kamiya N. Extending the Half-Life of a Protein in Vivo by Enzymatic Labeling with Amphiphilic Lipopeptides. Bioconjug Chem 2021;32:655-60. [PMID: 33689283 DOI: 10.1021/acs.bioconjchem.1c00027] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
46 Ganesh AN, Heusser C, Garad S, Sánchez-félix MV. Patient-centric design for peptide delivery: Trends in routes of administration and advancement in drug delivery technologies. Medicine in Drug Discovery 2021;9:100079. [DOI: 10.1016/j.medidd.2020.100079] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
47 Mallart S, Ingenito R, Bianchi E, Bresciani A, Esposito S, Gallo M, Magotti P, Monteagudo E, Orsatti L, Roversi D, Santoprete A, Tucci F, Veneziano M, Bartsch R, Boehm C, Brasseur D, Bruneau P, Corbier A, Froissant J, Gauzy-Lazo L, Gervat V, Marguet F, Menguy I, Minoletti C, Nicolas MF, Pasquier O, Poirier B, Raux A, Riva L, Janiak P, Strobel H, Duclos O, Illiano S. Identification of Potent and Long-Acting Single-Chain Peptide Mimetics of Human Relaxin-2 for Cardiovascular Diseases. J Med Chem 2021;64:2139-50. [PMID: 33555858 DOI: 10.1021/acs.jmedchem.0c01533] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
48 Kalomoiri P, Rodríguez-Rodríguez C, Sørensen KK, Bergamo M, Saatchi K, Häfeli UO, Jensen KJ. Bioimaging and Biodistribution of the Metal-Ion-Controlled Self-Assembly of PYY3-36 Studied by SPECT/CT. Chembiochem 2020;21:3338-48. [PMID: 32667131 DOI: 10.1002/cbic.202000266] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
49 Ibeanu N, Egbu R, Onyekuru L, Javaheri H, Khaw PT, Williams GR, Brocchini S, Awwad S. Injectables and Depots to Prolong Drug Action of Proteins and Peptides. Pharmaceutics 2020;12:E999. [PMID: 33096803 DOI: 10.3390/pharmaceutics12100999] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
50 Wasko J, Wolszczak M, Kaminski ZJ, Steblecka M, Kolesinska B. Human Serum Albumin Binds Native Insulin and Aggregable Insulin Fragments and Inhibits Their Aggregation. Biomolecules 2020;10:E1366. [PMID: 32992893 DOI: 10.3390/biom10101366] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
51 Kim TY, Nam YR, Park JH, Lee DE, Kim HS. Site-Specific Lipidation of a Small-Sized Protein Binder Enhances the Antitumor Activity through Extended Blood Half-Life. ACS Omega 2020;5:19778-84. [PMID: 32803073 DOI: 10.1021/acsomega.0c02555] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
52 Abdallah M, Müllertz OO, Styles IK, Mörsdorf A, Quinn JF, Whittaker MR, Trevaskis NL. Lymphatic targeting by albumin-hitchhiking: Applications and optimisation. J Control Release 2020;327:117-28. [PMID: 32771478 DOI: 10.1016/j.jconrel.2020.07.046] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 9.7] [Reference Citation Analysis]
53 Yang SH, Clemett CA, Brimble MA, O'Carroll SJ, Harris PWR. Synthesis and biological evaluation of S-lipidated lipopeptides of a connexin 43 channel inhibitory peptide. RSC Med Chem 2020;11:1041-7. [PMID: 33479696 DOI: 10.1039/d0md00172d] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
54 Østergaard M, Mishra NK, Jensen KJ. The ABC of Insulin: The Organic Chemistry of a Small Protein. Chem Eur J 2020;26:8341-57. [DOI: 10.1002/chem.202000337] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
55 Tang C, Li Q, Deng X, Wu W, Liao L, Liang K, Huo R, Li C, Han J, Tang W, Jiang N. Discovery of lixisenatide analogues as long-acting hypoglycemic agents using novel peptide half-life extension technology based on mycophenolic acid. RSC Adv 2020;10:12089-104. [PMID: 35496622 DOI: 10.1039/d0ra01002b] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
56 Wenskowsky L, Wagner M, Reusch J, Schreuder H, Matter H, Opatz T, Petry SM. Resolving Binding Events on the Multifunctional Human Serum Albumin. ChemMedChem 2020;15:738-43. [PMID: 32162429 DOI: 10.1002/cmdc.202000069] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
57 van der Velden WJC, Heitman LH, Rosenkilde MM. Perspective: Implications of Ligand-Receptor Binding Kinetics for Therapeutic Targeting of G Protein-Coupled Receptors. ACS Pharmacol Transl Sci 2020;3:179-89. [PMID: 32296761 DOI: 10.1021/acsptsci.0c00012] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 6.7] [Reference Citation Analysis]
58 Yang S, Hermant YOJ, Harris PWR, Brimble MA. Replacement of the Acrid tert -Butylthiol and an Improved Isolation Protocol for Cysteine Lipidation on a Peptide or Amino Acid (CLipPA): Replacement of the Acrid tert -Butylthiol and an Improved Isolation Protocol for Cysteine Lipidation on a Peptide or Amino Acid (CLipPA). Eur J Org Chem 2020;2020:944-7. [DOI: 10.1002/ejoc.201901696] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
59 Wolff M, Schüler A, Gast K, Seckler R, Evers A, Pfeiffer-marek S, Kurz M, Nagel N, Haack T, Wagner M, Thalhammer A. Self-Assembly of Exendin-4-Derived Dual Peptide Agonists is Mediated by Acylation and Correlated to the Length of Conjugated Fatty Acyl Chains. Mol Pharmaceutics 2020;17:965-78. [DOI: 10.1021/acs.molpharmaceut.9b01195] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
60 Venanzi M, Savioli M, Cimino R, Gatto E, Palleschi A, Ripani G, Cicero D, Placidi E, Orvieto F, Bianchi E. A spectroscopic and molecular dynamics study on the aggregation process of a long-acting lipidated therapeutic peptide: the case of semaglutide. Soft Matter 2020;16:10122-31. [DOI: 10.1039/d0sm01011a] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
61 Hermant YO, Cameron AJ, Harris PWR, Brimble MA. Synthesis of Antimicrobial Lipopeptides Using the “CLipPA” Thiol-Ene Reaction. Methods in Molecular Biology 2020. [DOI: 10.1007/978-1-0716-0227-0_18] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
62 Knerr PJ, Mowery SA, Finan B, Perez-Tilve D, Tschöp MH, DiMarchi RD. Selection and progression of unimolecular agonists at the GIP, GLP-1, and glucagon receptors as drug candidates. Peptides 2020;125:170225. [PMID: 31786282 DOI: 10.1016/j.peptides.2019.170225] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
63 Tan H, Su W, Zhang W, Wang P, Sattler M, Zou P. Recent Advances in Half-life Extension Strategies for Therapeutic Peptides and Proteins. Curr Pharm Des 2018;24:4932-46. [PMID: 30727869 DOI: 10.2174/1381612825666190206105232] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
64 Fink K, Boratyński J, Paprocka M, Goszczyński TM. Metallacarboranes as a tool for enhancing the activity of therapeutic peptides. Ann N Y Acad Sci 2019;1457:128-41. [PMID: 31407357 DOI: 10.1111/nyas.14201] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
65 Bech EM, Kaiser A, Bellmann-sickert K, Nielsen SS, Sørensen KK, Elster L, Hatzakis N, Pedersen SL, Beck-sickinger AG, Jensen KJ. Half-Life Extending Modifications of Peptide YY 3–36 Direct Receptor-Mediated Internalization. Mol Pharmaceutics 2019;16:3665-77. [DOI: 10.1021/acs.molpharmaceut.9b00554] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
66 Zorzi A, Linciano S, Angelini A. Non-covalent albumin-binding ligands for extending the circulating half-life of small biotherapeutics. Medchemcomm 2019;10:1068-81. [PMID: 31391879 DOI: 10.1039/c9md00018f] [Cited by in Crossref: 71] [Cited by in F6Publishing: 71] [Article Influence: 17.8] [Reference Citation Analysis]
67 Sun L, Han J, Chen X, Han Y, Wu L, E X. Novel mono-lipidated dimeric glucagon-like peptide-1 receptor agonist with improved long-acting and hypoglycemic activity. RSC Adv 2019;9:9654-62. [DOI: 10.1039/c9ra00833k] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
68 Pawlas J, Antonic B, Lundqvist M, Svensson T, Finnman J, Rasmussen JH. 2D green SPPS: green solvents for on-resin removal of acid sensitive protecting groups and lactamization. Green Chem 2019;21:2594-600. [DOI: 10.1039/c9gc00898e] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 6.3] [Reference Citation Analysis]
69 Menacho-Melgar R, Decker JS, Hennigan JN, Lynch MD. A review of lipidation in the development of advanced protein and peptide therapeutics. J Control Release 2019;295:1-12. [PMID: 30579981 DOI: 10.1016/j.jconrel.2018.12.032] [Cited by in Crossref: 48] [Cited by in F6Publishing: 49] [Article Influence: 9.6] [Reference Citation Analysis]